The 2026-2027 RSV Infant Immunisation Programme will officially launch on 27 August. Healthcare professionals will play an important role in delivering the programme and supporting parents to protect their babies against RSV. Below are some key clinical updates to support you as we prepare for this year’s programme. Nirsevimab (Beyfortus®, Sanofi) is a long-acting monoclonal […]
